Market Challenges And Opportunities

Restraints & Challenges:

High cost of diphtheria vaccines
Inadequate access to vaccines in under developed countries

Global Diphtheria Vaccine Market: Restraint

The side effects of Diphtheria vaccine

The major factors that can hamper growth of the global diphtheria vaccine market over the forecast period include high cost of the diphtheria vaccines and inadequate access to vaccines in under developed countries. For instance, according to centers for disease control and prevention (CDC) in November 2022, the cost of Quadracel, a diphtheria vaccine manufactured by Sanofi Pasteur, a vaccines division of the French multinational pharmaceutical company Sanofi, is US$ 58.35 for a single vial. Key market player should focus on developing cost effective vaccine.

Diphtheria Vaccine Market Report Snapshots